On July 27-29, the 2023 Shenzhen International Biomedical Industry Innovation and Development Conference was held in Shenzhen under the guidance of Shenzhen Municipal People's Government, jointly sponsored by Shenzhen Pingshan District People's Government, Shenzhen Dapeng New District Management Committee, Shenzhen Development and Reform Commission and Shenzhen Science and Technology Innovation Committee. With the theme of "Cross-border integration and goes deep into the future", the conference conducted in-depth discussions on the latest national medical and health industry policies, cutting-edge technologies and investments, IT and BT integration, achievements transformation and cooperation with Industry-University-Research, and enterprises' going out to sea and internationalization. Shi Wenzhao, Chairman and CEO of DHCtech, was invited to attend the conference and deliver a speech at the keynote forum, which attracted wide attention.

Shi Wenzhao delivered a keynote speech entitled Innovative Application of Medical Big Data and Medical AI in the Big Model Era at the keynote forum of the conference, taking the development of artificial intelligence technology and key events in the field of medical AI as the breakthrough point, and pointed out the significance and future development trend of technological innovation in the development of medical and health industry. With the advent of the era of big model, the application of big model will become the key force of medical reform, and play an important role in the fields of massive medical data analysis, clinical decision-making, promoting the development of bioinformatics technology, and pharmaceutical or molecular diagnosis.

Then he introduced the AI strategy upgrade and application innovation of DHCtech in the era of big model. As one of the pioneers and leading enterprises in the medical big data AI industry, DHCtech is depending on technology to complete subversive innovation, realize the upgrade of multi-modal big model, CV big model and NLP big model, and fully lead the multi-modal big data medical AI industry. The company is polishing the whole-system products and applications in three major fields: medical big data, intelligent imaging and precision medicine, providing comprehensive solutions for the government, hospitals and pharmaceutical companies, and building a sustainable expansion model of "platform+"based on the above three business segments through the innovative technology of "big data +AI", namely "platform+international technology", "platform+technology acquisition" and "platform+service empowerment".

Tian Yuan, the founder and chairman of China Yabuli Entrepreneur Forum, presided over the opening ceremony as the president of the conference. Shen Jianzhong, deputy director of China Biotechnology Development Center, Zhang Lihe, academician of China Academy of Sciences, Ma Dawei, academician of China Academy of Sciences, Chen Fener, academician of China Academy of Engineering, Wang Xiaobin, academician of American National Academy of Engineering, Lu Hongzhou, academician of American Academy of Microbiology, Zhu Yizhen, academician of European Academy of Science and Art, Zhang Dan, foreign academician of Russian Academy of Engineering, Zhang Xumu, president of Iflytek Smart Medical Division, Zhang Guodong, General Manager of Tencent Health Smart Medical, Qiao Nan, Chief Scientist of Huawei Cloud Medical, Zhao Hongyun, Professor of Cancer Prevention Center of Sun Yat-sen University, Zhao Bingxiang, President of China Resources Sanjiu, and other well-known experts and scholars at home and abroad and leaders of enterprises and institutions attended the keynote forum at the same time to give keynote speeches or share their views.

On the eve of the opening of the conference, the Industry Leaders Summit hosted by Shenzhen Pingshan District People's Government and Shenzhen Municipal Bureau of Commerce, and hosted by Pingshan District Science and Technology Innovation Bureau and Pingshan District Investment Promotion Service Department specially invited more than 50 industry leaders to gather together to discuss the way to break the situation of biotechnology and talk about the pioneers of biomedicine. Shi Wenzhao was invited to appear on the meeting.

Shi Wenzhao believed that the core of medical big data is to transform unstructured and nonstandard text information written by doctors into structured and standardized data for training AI to process. He indicated that image data that used to need manual identification can now be identified by AI. Technology needs to turn into products and complete the cycle before enterprises can develop, and DHCtech is taking the chance of intelligent construction of hospitals to help them build a big data platform and complete a closed-loop business.

The impact of AI and big data on the health care industry is growing. As an early established medical big data and artificial intelligence company in China, DHCtech has been in the field of smart medical care for many years, focusing on four business areas: medical big data, intelligent imaging platform, precision medical care and digital services of pharmaceutical companies. It is one of the few companies in China that can realize multi-group learning and multi-modal big data closed-loop integration.

Over the years, DHCtech has possessed the full-chain, one-stop intelligent data processing capability, broken through the barriers between clinical text data, image data and histology data, and successfully built a number of national, disease-specific and multi-modal big data platforms, which promoted the diagnosis and treatment of major diseases and high-risk chronic diseases in healthy China, made high-quality medical resources benefit the general public, and promoted a number of breakthrough medical clinical and scientific research achievements.

For example, DHCtech cooperated with Southern Hospital of Southern Medical University to build a hospital-wide big data platform, which was selected as a big data demonstration application project and a typical case of digital health by the Ministry of Industry and Information Technology and the Health and Health Commission. One-stop solutions, such as CDSS, imaging, pathological AI, radiotherapy cloud, MDT and special disease management, are provided from the core diagnosis and treatment links of the whole process of screening-diagnosis-treatment-follow-up, which have been implemented in the Cancer Hospital of China Academy of Medical Sciences, Chinese PLA General Hospital and the First Affiliated Hospital of Zhengzhou University. Through multi-level and multi-scenario big data AI solutions, DHCtech provides multi-dimensional products and solutions that meet different development needs for different types and levels of hospitals, fully helping the digital transformation and high-quality development of public hospitals, and promoting the comprehensive integration and development of AI and medical care.